RecruitingNot applicableNCT07062172

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Checked against the public recordLast updated Jul 14, 2025 · Source: ClinicalTrials.gov

StatusRecruiting
PhaseNot applicable
U.S. locations1
SponsorUniversity of California, Irvine
01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of California, Irvine
Interventions being studied
Diagnostic Test: Low Dose CT Scan
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Cohort A: Inclusion Criteria: * Current diagnosis of lung cancer with a driver mutation. * Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.) * Able and willing to give informed consent. * Able and willing to complete the screening questionnaire. Cohort A: Exclusion Criteria: * There are no exclusion criteria for Cohort A. Cohort B: Inclusion Criteria: * Age 40 - 80. * Must have a first degree relative (mother, father, sibling, biological child) eligible for Cohort A. Note: Multiple first degree relatives of a Cohort A eligible participant may be approached for participation into the trial. * Smoked \< 20 pack years; a. Pack years = numbers of packs per day × number of years smoked; b. One pack year is the equivalent of smoking an average of 20 cigarettes (1 pack) per day for a year. * Be able to undergo a low dose chest CT scan. * If an upper respiratory infection (pneumonia, COVID19, flu, etc.) occurred in the last 3 months, this infection must have resolved by time of enrollment. * Able and willing to provide informed consent. * Able and willing to comply with the protocol requirements Cohort B: Exclusion Criteria: * Previous history of lung cancers. * Symptoms suggestive of presence of current lung cancer, including (but not limited to): unexplained weight loss of over 15 pounds within the last 12 months or unexplained hemoptysis. * Pregnant at time of enrollment. * History of any type of cancer within 5 years, with the exception of in situ carcinomas and non-melanoma skin cancers (if excised). * Current smoker. * Smoked ≥ 20 pack years. * Had a chest CT scan within 1 year of study entry.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Chao Family Comprehensive Cancer Center University of California, IrvineOrange, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 14, 2025. Always confirm current availability with the study team.

View original record ↗